Nave R - Search Results

1

A Thorough QT Study of Teduglutide in Healthy Subjects.

Hartmann M, Timmer W, Schultz A, Nave R, Luehmann R, Krause S, Lahu G, Scholpp J. Hartmann M, et al. Among authors: nave r. Clin Pharmacol Drug Dev. 2012 Apr;1(2):57-66. doi: 10.1177/2160763X12438745. Clin Pharmacol Drug Dev. 2012. PMID: 27121220

2

Pharmacokinetics of teduglutide in subjects with renal impairment.

Nave R, Halabi A, Herzog R, Schaffer P, Diefenbach J, Krause S, Berghöfer P, Lahu G, Hartmann M. Nave R, et al. Eur J Clin Pharmacol. 2013 May;69(5):1149-55. doi: 10.1007/s00228-012-1455-7. Epub 2012 Nov 28. Eur J Clin Pharmacol. 2013. PMID: 23187965 Clinical Trial.

3

Single-dose and multi-dose delivery systems for intranasal fentanyl spray are bioequivalent as demonstrated in a replicate pharmacokinetic study.

Nave R, Connolly SM, Popper L, Lahu G, Schmitt H. Nave R, et al. Int J Clin Pharmacol Ther. 2012 Oct;50(10):751-9. doi: 10.5414/CP201729. Int J Clin Pharmacol Ther. 2012. PMID: 22943926 Clinical Trial.

4

Population pharmacokinetic meta-analysis of intranasal fentanyl spray as a means to enrich pharmacokinetic information for patients with cancer breakthrough pain.

Kaessner N, Nave R, Roepcke S, Facius A, Lahu G. Kaessner N, et al. Among authors: nave r. Int J Clin Pharmacol Ther. 2012 Sep;50(9):665-77. doi: 10.5414/CP201737. Int J Clin Pharmacol Ther. 2012. PMID: 22784611

5

Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.

Xu J, Nave R, Lahu G, Derom E, Derendorf H. Xu J, et al. Among authors: nave r. J Clin Pharmacol. 2010 Oct;50(10):1118-27. doi: 10.1177/0091270009354994. Epub 2010 Feb 11. J Clin Pharmacol. 2010. PMID: 20150524 Clinical Trial.

6

An innovative phase I population pharmacokinetic approach to investigate the pharmacokinetics of an intranasal fentanyl spray in healthy subjects.

Plock N, Facius A, Hartmann L, Baumann S, Nave R. Plock N, et al. Among authors: nave r. Int J Clin Pharmacol Ther. 2013 Jun;51(6):495-508. doi: 10.5414/CP201867. Int J Clin Pharmacol Ther. 2013. PMID: 23611571 Clinical Trial.

7

Absence of Drug-Drug Interaction of Anastrozole on Levonorgestrel Delivered Simultaneously by an Intravaginal Ring: Results of a Phase 2 Trial.

Nave R, Mellinger U, Klein S, Höchel J, Schmitz H. Nave R, et al. J Clin Pharmacol. 2019 Jul;59(7):1022-1028. doi: 10.1002/jcph.1396. Epub 2019 Feb 21. J Clin Pharmacol. 2019. PMID: 30791125 Free PMC article. Clinical Trial.

8

Comparison of In Vitro and In Vivo Percutaneous Absorption Across Human Skin Using BAY1003803 Formulated as Ointment and Cream.

Günther C, Kowal K, Schmidt T, Jambrecina A, Toner F, Nave R. Günther C, et al. Among authors: nave r. Clin Pharmacol Drug Dev. 2020 Jul;9(5):582-592. doi: 10.1002/cpdd.736. Epub 2019 Oct 24. Clin Pharmacol Drug Dev. 2020. PMID: 31647607 Free PMC article.

9

Pharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similar.

Nave R, Gunawardena KA, Zech K, Bethke TD. Nave R, et al. Int J Clin Pharmacol Ther. 2006 Jan;44(1):1-7. doi: 10.5414/cpp44001. Int J Clin Pharmacol Ther. 2006. PMID: 16425964 Clinical Trial.

10

Model-Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms.

Reinecke I, Schultze-Mosgau MH, Nave R, Schmitz H, Ploeger BA. Reinecke I, et al. Among authors: nave r. J Clin Pharmacol. 2017 May;57(5):640-651. doi: 10.1002/jcph.846. Epub 2016 Dec 7. J Clin Pharmacol. 2017. PMID: 27925651 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters